Cargando…
Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy
Recent evidence suggests that myeloid cells are critical in cancer development and therapy resistance processes. Pharmacological targeting of tumor-associated myeloid cells is an emerging approach among upcoming immune therapies. Surprisingly, myeloid cells are heterogeneous, including a subset of t...
Autores principales: | Johnson, Benjamin W., Achyut, Bhagelu R., Fulzele, Sadanand, Mondal, Ashis K., Kolhe, Ravindra, Arbab, Ali S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165286/ https://www.ncbi.nlm.nih.gov/pubmed/30158456 http://dx.doi.org/10.3390/ijms19092565 |
Ejemplares similares
-
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
por: Achyut, Bhagelu R, et al.
Publicado: (2016) -
Immune Factors Drive Expression of SARS-CoV-2 Receptor Genes Amid Sexual Disparity
por: Vashisht, Ashutosh, et al.
Publicado: (2023) -
Cancer Therapeutics Following Newton’s Third Law
por: Arbab, Ali S., et al.
Publicado: (2016) -
Nanostring-Based Identification of the Gene Expression Profile in Trigger Finger Samples
por: Kolhe, Ravindra, et al.
Publicado: (2021) -
Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic
por: Sahajpal, Nikhil S., et al.
Publicado: (2021)